1. Home
  2. ICCC vs IOBT Comparison

ICCC vs IOBT Comparison

Compare ICCC & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$4.90

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.71

Market Cap

57.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
IOBT
Founded
1982
2014
Country
United States
Denmark
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.5M
57.2M
IPO Year
1987
2021

Fundamental Metrics

Financial Performance
Metric
ICCC
IOBT
Price
$4.90
$0.71
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$3.50
AVG Volume (30 Days)
18.4K
907.6K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$27,769,304.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.59
N/A
Revenue Growth
16.49
N/A
52 Week Low
$3.75
$0.32
52 Week High
$7.60
$2.79

Technical Indicators

Market Signals
Indicator
ICCC
IOBT
Relative Strength Index (RSI) 38.84 43.00
Support Level $4.52 $0.69
Resistance Level $5.36 $0.83
Average True Range (ATR) 0.29 0.10
MACD -0.05 -0.00
Stochastic Oscillator 25.33 25.32

Price Performance

Historical Comparison
ICCC
IOBT

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: